Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001960596-25-000006
Filing Date
2025-11-12
Accepted
2025-11-12 16:05:00
Documents
2
Period of Report
2025-11-10

Document Format Files

Seq Description Document Type Size
1 form3-11122025_091156.html 3  
1 form3-11122025_091156.xml 3 1721
2 ex24-11122025_091156.htm EX-24 5300
  Complete submission text file 0001960596-25-000006.txt   8678
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Lawver Teri L (Reporting) CIK: 0001960596 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 251472573